Skip to main content
Clinical Trials/CTRI/2021/10/037667
CTRI/2021/10/037667
Not yet recruiting
Phase 2

AN OPEN LABEL SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFECT OF VAMANA AND VIRECHANA IN THE MANAGEMENT OF PSORIASIS AND ITS IMPACT ON IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS

All India Institute of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
All India Institute of Ayurveda
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • PASI Score: \> 10
  • Chronicity: 5\-10 years
  • Patients having the clinical features of Psoriasis (Kitibha Kushtha).

Exclusion Criteria

  • PASI score \<10 Mild score
  • Chronicity of more than 10 years
  • Patients with Severe Systemic disorders.
  • Pregnant women and lactating mothers
  • Patients unfit for Rookshana Snehana, Swedana,Vamana and Virechana Karma.

Outcomes

Primary Outcomes

Not specified

Similar Trials